查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1706220

2025年紅色生物技術全球市場報告

Red Biotechnology Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年紅色生物技術市場規模將快速成長。到 2029 年，這一數字將成長至 9,635.5 億美元，複合年成長率為 11.1%。預測期內成長的主要驅動力包括個人化醫療的興起、人口老化、研發投資、數位健康整合以及醫療保健基礎設施的擴大。預測期內的全球趨勢包括生技藥品和生物相似藥的擴張、機器學習的整合、基於微生物的治療方法的開發、關注罕見疾病和孤兒病、全球合作和夥伴關係。

由於個人化醫療需求的不斷成長，紅色生物技術市場預計將實現成長。個人化醫療涉及根據個人的特徵（例如遺傳和生活方式）量身定做治療，以最佳化療效並減少副作用。這種需求是由更有效的治療方法、基因組學的進步、疾病的日益複雜性以及支持性法規的可能性所驅動。 Red 生物技術利用遺傳訊息，根據患者的基因特徵和疾病屬性量身定做治療方案，促進個人化藥物的開發。例如，精準醫學聯盟報告稱，2024 年 2 月，FDA核准了16 種新的 2023 年罕見疾病個人化治療方法，而 2022 年則為 6 種。

紅色生物技術領域的主要企業正專注於開發生物相似藥等創新產品，以滿足日益成長的個人化醫療需求並應對複雜疾病。生物相似藥是與現有已通過核准的參考生技藥品非常相似的生物製藥，可提供具有成本效益的替代品。例如，2022 年 6 月，安進公司獲得 FDA核准Liavni（Rituximab-arx），這是Rituxan （Rituximab）的生物相似藥，用於治療中度至重度類風濕性關節炎(RA) 成年患者。這一里程碑凸顯了生物相似藥的發展，生物學名藥旨在以較低的成本模仿現有的生物製藥。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、感染疾病、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球紅色生物技術PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球紅色生物技術市場：成長率分析
  • 全球紅色生物技術市場表現：規模與成長，2019-2024
  • 全球紅色生物技術市場預測：2024-2029 年及 2034 年規模與成長
  • 全球紅色生物技術總目標市場（TAM）

第6章市場區隔

  • 全球紅色生物技術市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 單株抗體
  • 多株抗體
  • 重組蛋白
  • 疫苗
  • 細胞免疫療法產品
  • 基因治療產品
  • 細胞治療產品
  • 組織工程產品
  • 其他產品
  • 全球紅色生物技術市場：按應用、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 藥物研發
  • 動物生物技術
  • 環境生物技術
  • 醫學生物技術
  • 工業生物技術
  • 農業生物技術
  • 其他用途
  • 全球紅色生物技術市場：依最終用戶、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 生物製藥業
  • 契約製造組織 (CMO) 和合約研究組織 (CRO)
  • 其他最終用戶
  • 全球紅色生物技術市場單株抗體細分市場（按類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 治療性單株抗體
  • 診斷性單株抗體
  • 單株抗體生物相似藥
  • 標靶單株抗體（癌症、自體免疫疾病）
  • 全球紅色生物技術市場多株抗體細分（按類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 診斷性多多株抗體
  • 治療性多株多株抗體
  • 獸用多株多株抗體
  • 調查多多株抗體
  • 全球紅色生物技術市場重組蛋白細分市場（按類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 酵素替代療法
  • 生長因子和荷爾蒙
  • 凝血因子濃縮物
  • 干擾素和細胞激素
  • 全球紅色生物技術市場，依疫苗類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 預防疫苗（流感、COVID-19、HPV）
  • 治療性疫苗（癌症疫苗）
  • DNA或RNA疫苗
  • 蛋白質次單元疫苗
  • 全球紅色生物技術市場細胞免疫療法產品類型細分、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
  • Car-T細胞療法
  • T細胞受體治療
  • NK細胞療法
  • 基於樹突狀細胞的免疫療法
  • 全球紅色生物技術市場基因治療產品細分（按類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 基因編輯（基於 Crispr 的治療方法）
  • 基於病毒載體的基因治療
  • 基因靜默療法
  • 體內基因治療產品
  • 全球紅色生物技術市場細胞治療產品細分（按類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 幹細胞療法
  • 再生細胞療法（間質幹細胞）
  • 自體細胞療法
  • 同種異體細胞治療
  • 全球紅色生物技術市場組織工程產品類型細分、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 皮膚和軟骨工程產品
  • 骨骼和肌肉再生產品
  • 心血管組織工程
  • 神經組織工程
  • 全球紅色生物技術市場、其他產品細分、按類型、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 血液和血液成分（例如血液替代品）
  • 蛋白質治療學
  • 診斷試劑套件和工具（生物標記、檢測試劑）
  • 再生醫學產品

第7章 區域和國家分析

  • 全球紅色生物技術市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球紅色生物技術市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 紅色生物技術市場：競爭格局
  • 紅色生物技術市場：公司簡介
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
    • GSK plc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Takeda Pharmaceutical Company Limited
  • Eli Lilly and Company
  • Gilead Sciences
  • Amgen Inc.
  • Merck KGaA
  • Moderna Inc.
  • Regeneron Pharmaceuticals Inc.
  • Astellas Pharma Inc.
  • Biogen Inc.
  • Boehringer Ingelheim International GmbH
  • BioMarin Pharmaceutical Inc.
  • Vir Biotechnology
  • Alnylam Pharmaceuticals, Inc.
  • Ultragenyx Pharmaceutical
  • BioCryst Pharmaceuticals

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年紅色生物技術市場：提供新機會的國家
  • 2029年紅色生物技術市場：細分領域帶來新機會
  • 2029年紅色生物技術市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r31095

Red biotechnology, a branch of biotechnology, focuses on medical and pharmaceutical applications, utilizing biological systems and organisms to develop products and technologies for healthcare. These include pharmaceuticals, diagnostic tests, and therapies to treat diseases and enhance human health.

The main products in red biotechnology encompass monoclonal antibodies, polyclonal antibodies, recombinant proteins, vaccines, cell-based immunotherapy products, gene therapy products, cell therapy products, tissue-engineered products, among others. Monoclonal antibodies, for instance, are lab-made proteins that mimic the immune system's ability to combat pathogens, finding application in targeted therapies for conditions such as cancer and autoimmune disorders. Red biotechnology spans drug discovery, animal biotechnology, environmental biotechnology, medical biotechnology, industrial biotechnology, agricultural biotechnology, catering to end-users such as the biopharmaceutical industry, contract manufacturing organizations (CMOs), contract research organizations (CROs), research institutes, and more.

The red biotechnology market research report is one of a series of new reports from The Business Research Company that provides red biotechnology market statistics, including the red biotechnology industry global market size, regional shares, competitors with the red biotechnology market share, detailed red biotechnology market segments, market trends, and opportunities, and any further data you may need to thrive in the red biotechnology industry. These red biotechnology market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The red biotechnology market size has grown rapidly in recent years. It will grow from $566.28 billion in 2024 to $631.45 billion in 2025 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to advancements in genetic engineering, stem cell research, growth of biotech startups, regulatory frameworks, biotech funding, and investment.

The red biotechnology market size is expected to see rapid growth in the next few years. It will grow to $963.55 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to the expansion of personalized medicine, the aging population, investment in research and development, digital health integration, and the expansion of healthcare infrastructure. Major trends in the forecast period include the expansion of biologics and biosimilars, integration of machine learning, development of microbiome-based therapies, focus on rare and orphan diseases, global collaboration, and partnerships.

The red biotechnology market is set to experience growth, driven by the increasing demand for personalized medicine. Personalized medicine tailors medical treatment to individual characteristics such as genetics or lifestyle to optimize effectiveness and reduce adverse effects. This demand is fueled by the potential for more effective treatments, advances in genomics, growing disease complexities, and supportive regulations. Red biotechnology facilitates the development of personalized medicines by leveraging genetic information to customize treatments based on a patient's genetic profile and disease attributes. For example, in February 2024, the FDA approved 16 novel personalized therapies for rare diseases in 2023, compared to six in 2022, as reported by the Personalized Medicine Coalition.

Leading companies in the red biotechnology sector are concentrating on developing innovative products such as biosimilars to cater to the rising demand for personalized medicine and tackle disease complexities. Biosimilars are biological products closely resembling existing approved reference biologics, offering cost-effective alternatives. For instance, in June 2022, Amgen Inc. obtained FDA approval for Riabni (rituximab-arrx), a biosimilar to Rituxan (rituximab), for treating adults with moderate to severe rheumatoid arthritis (RA). This milestone underscores the development of biosimilars, designed to mimic existing biological products at lower costs.

In March 2023, Ipsen Biopharmaceuticals Inc. acquired Albireo Pharma Inc. to enhance its Rare Disease portfolio with therapies for rare cholestatic liver diseases. Albireo Pharma Inc. specializes in novel bile acid modulators for orphan pediatric liver diseases, contributing to Ipsen's scientific and commercial capabilities.

Major companies operating in the red biotechnology market are Pfizer Inc., F. Hoffmann-La Roche AG, Bayer AG, Bristol-Myers Squibb Company, GSK plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences, Amgen Inc., Merck KGaA, Moderna Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Boehringer Ingelheim International GmbH, BioMarin Pharmaceutical Inc., Vir Biotechnology, Alnylam Pharmaceuticals, Inc., Ultragenyx Pharmaceutical, BioCryst Pharmaceuticals, Sangamo Therapeutics, Inc., Denali Therapeutics, Atara Biotherapeutics, Beam Therapeutics, Umoja Biopharma

North America was the largest region in the red biotechnology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the red biotechnology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the red biotechnology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The red biotechnology market consists of sales of diagnostic testing kits, biological sensors, regenerative medicine, and antibiotics. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Red Biotechnology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on red biotechnology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for red biotechnology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The red biotechnology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Monoclonal Antibodies; Polyclonal Antibodies; Recombinant Proteins; Vaccines; Cell-Based Immunotherapy Products; Gene Therapy Products; Cell Therapy Products; Tissue-Engineered Products; Other Products
  • 2) By Application: Drug Discovery And Development; Animal Biotechnology; Environmental Biotechnology; Medical Biotechnology; Industrial Biotechnology; Agricultural Biotechnology; Other Applications
  • 3) By End-User: Biopharmaceutical Industry; Contract Manufacturing Organization (CMO) And Contract Research Organization (CRO) Research Institutes; Other End Users
  • Subsegments:
  • 1) By Monoclonal Antibodies: Therapeutic Monoclonal Antibodies; Diagnostic Monoclonal Antibodies; Biosimilars Of Monoclonal Antibodies; Targeted Monoclonal Antibodies (For Cancer, Autoimmune Diseases)
  • 2) By Polyclonal Antibodies: Diagnostic Polyclonal Antibodies; Therapeutic Polyclonal Antibodies; Veterinary Polyclonal Antibodies; Research Polyclonal Antibodies
  • 3) By Recombinant Proteins: Enzyme Replacement Therapies; Growth Factors And Hormones; Clotting Factor Products; Interferons And Cytokines
  • 4) By Vaccines: Preventive Vaccines (For Influenza, Covid-19, Hpv); Therapeutic Vaccines (Cancer Vaccines); Dna Or Rna-Based Vaccines; Protein Subunit Vaccines
  • 5) By Cell-Based Immunotherapy Products: Car-T-Cell Therapies; T-Cell Receptor Therapies; Nk Cell Therapies; Dendritic Cell-Based Immunotherapies
  • 6) By Gene Therapy Products: Gene Editing (Crispr-Based Therapies); Viral Vector-Based Gene Therapies; Gene Silencing Therapies; In Vivo Gene Therapy Products
  • 7) By Cell Therapy Products: Stem Cell Therapies; Regenerative Cell Therapies (Mesenchymal Stem Cells); Autologous Cell Therapies; Allogeneic Cell Therapies
  • 8) By Tissue-Engineered Products: Skin And Cartilage Engineered Products; Bone And Muscle Regenerative Products; Cardiovascular Tissue Engineering; Neural Tissue Engineering
  • 9) By Other Products: Blood And Blood Components (E.g., Blood Substitutes); Protein Therapeutics; Diagnostic Kits And Tools (Biomarkers, Assays); Regenerative Medicine Products
  • Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche AG; Bayer AG; Bristol-Myers Squibb Company; GSK plc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Red Biotechnology Market Characteristics

3. Red Biotechnology Market Trends And Strategies

4. Red Biotechnology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Red Biotechnology Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Red Biotechnology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Red Biotechnology Market Growth Rate Analysis
  • 5.4. Global Red Biotechnology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Red Biotechnology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Red Biotechnology Total Addressable Market (TAM)

6. Red Biotechnology Market Segmentation

  • 6.1. Global Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Recombinant Proteins
  • Vaccines
  • Cell-Based Immunotherapy Products
  • Gene Therapy Products
  • Cell Therapy Products
  • Tissue-Engineered Products
  • Other Products
  • 6.2. Global Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Discovery And Development
  • Animal Biotechnology
  • Environmental Biotechnology
  • Medical Biotechnology
  • Industrial Biotechnology
  • Agricultural Biotechnology
  • Other Applications
  • 6.3. Global Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biopharmaceutical Industry
  • Contract Manufacturing Organization (CMO) And Contract Research Organization (CRO) Research Institutes
  • Other End Users
  • 6.4. Global Red Biotechnology Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Therapeutic Monoclonal Antibodies
  • Diagnostic Monoclonal Antibodies
  • Biosimilars Of Monoclonal Antibodies
  • Targeted Monoclonal Antibodies (For Cancer, Autoimmune Diseases)
  • 6.5. Global Red Biotechnology Market, Sub-Segmentation Of Polyclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Polyclonal Antibodies
  • Therapeutic Polyclonal Antibodies
  • Veterinary Polyclonal Antibodies
  • Research Polyclonal Antibodies
  • 6.6. Global Red Biotechnology Market, Sub-Segmentation Of Recombinant Proteins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Enzyme Replacement Therapies
  • Growth Factors And Hormones
  • Clotting Factor Products
  • Interferons And Cytokines
  • 6.7. Global Red Biotechnology Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Preventive Vaccines (For Influenza, Covid-19, Hpv)
  • Therapeutic Vaccines (Cancer Vaccines)
  • Dna Or Rna-Based Vaccines
  • Protein Subunit Vaccines
  • 6.8. Global Red Biotechnology Market, Sub-Segmentation Of Cell-Based Immunotherapy Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Car-T-Cell Therapies
  • T-Cell Receptor Therapies
  • Nk Cell Therapies
  • Dendritic Cell-Based Immunotherapies
  • 6.9. Global Red Biotechnology Market, Sub-Segmentation Of Gene Therapy Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gene Editing (Crispr-Based Therapies)
  • Viral Vector-Based Gene Therapies
  • Gene Silencing Therapies
  • In Vivo Gene Therapy Products
  • 6.10. Global Red Biotechnology Market, Sub-Segmentation Of Cell Therapy Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Stem Cell Therapies
  • Regenerative Cell Therapies (Mesenchymal Stem Cells)
  • Autologous Cell Therapies
  • Allogeneic Cell Therapies
  • 6.11. Global Red Biotechnology Market, Sub-Segmentation Of Tissue-Engineered Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Skin And Cartilage Engineered Products
  • Bone And Muscle Regenerative Products
  • Cardiovascular Tissue Engineering
  • Neural Tissue Engineering
  • 6.12. Global Red Biotechnology Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood And Blood Components (E.g., Blood Substitutes)
  • Protein Therapeutics
  • Diagnostic Kits And Tools (Biomarkers, Assays)
  • Regenerative Medicine Products

7. Red Biotechnology Market Regional And Country Analysis

  • 7.1. Global Red Biotechnology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Red Biotechnology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Red Biotechnology Market

  • 8.1. Asia-Pacific Red Biotechnology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Red Biotechnology Market

  • 9.1. China Red Biotechnology Market Overview
  • 9.2. China Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Red Biotechnology Market

  • 10.1. India Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Red Biotechnology Market

  • 11.1. Japan Red Biotechnology Market Overview
  • 11.2. Japan Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Red Biotechnology Market

  • 12.1. Australia Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Red Biotechnology Market

  • 13.1. Indonesia Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Red Biotechnology Market

  • 14.1. South Korea Red Biotechnology Market Overview
  • 14.2. South Korea Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Red Biotechnology Market

  • 15.1. Western Europe Red Biotechnology Market Overview
  • 15.2. Western Europe Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Red Biotechnology Market

  • 16.1. UK Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Red Biotechnology Market

  • 17.1. Germany Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Red Biotechnology Market

  • 18.1. France Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Red Biotechnology Market

  • 19.1. Italy Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Red Biotechnology Market

  • 20.1. Spain Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Red Biotechnology Market

  • 21.1. Eastern Europe Red Biotechnology Market Overview
  • 21.2. Eastern Europe Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Red Biotechnology Market

  • 22.1. Russia Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Red Biotechnology Market

  • 23.1. North America Red Biotechnology Market Overview
  • 23.2. North America Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Red Biotechnology Market

  • 24.1. USA Red Biotechnology Market Overview
  • 24.2. USA Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Red Biotechnology Market

  • 25.1. Canada Red Biotechnology Market Overview
  • 25.2. Canada Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Red Biotechnology Market

  • 26.1. South America Red Biotechnology Market Overview
  • 26.2. South America Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Red Biotechnology Market

  • 27.1. Brazil Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Red Biotechnology Market

  • 28.1. Middle East Red Biotechnology Market Overview
  • 28.2. Middle East Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Red Biotechnology Market

  • 29.1. Africa Red Biotechnology Market Overview
  • 29.2. Africa Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Red Biotechnology Market Competitive Landscape And Company Profiles

  • 30.1. Red Biotechnology Market Competitive Landscape
  • 30.2. Red Biotechnology Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. GSK plc. Overview, Products and Services, Strategy and Financial Analysis

31. Red Biotechnology Market Other Major And Innovative Companies

  • 31.1. Takeda Pharmaceutical Company Limited
  • 31.2. Eli Lilly and Company
  • 31.3. Gilead Sciences
  • 31.4. Amgen Inc.
  • 31.5. Merck KGaA
  • 31.6. Moderna Inc.
  • 31.7. Regeneron Pharmaceuticals Inc.
  • 31.8. Astellas Pharma Inc.
  • 31.9. Biogen Inc.
  • 31.10. Boehringer Ingelheim International GmbH
  • 31.11. BioMarin Pharmaceutical Inc.
  • 31.12. Vir Biotechnology
  • 31.13. Alnylam Pharmaceuticals, Inc.
  • 31.14. Ultragenyx Pharmaceutical
  • 31.15. BioCryst Pharmaceuticals

32. Global Red Biotechnology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Red Biotechnology Market

34. Recent Developments In The Red Biotechnology Market

35. Red Biotechnology Market High Potential Countries, Segments and Strategies

  • 35.1 Red Biotechnology Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Red Biotechnology Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Red Biotechnology Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer